| Zugriffe | |
|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 297 |
| Mai 2024 | Juni 2024 | Juli 2024 | August 2024 | September 2024 | Oktober 2024 | November 2024 | |
|---|---|---|---|---|---|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 13 | 6 | 10 | 8 | 13 | 4 | 1 |
| Zugriffe | |
|---|---|
| 3_Chapter3_Materials_Methods.pdf | 225 |
| 6_Chapter6_References.pdf | 222 |
| 1_Chapter1_Introduction_aims_objectives.pdf | 186 |
| 7_Chapter7_Appendices_Aknowledgements.pdf | 156 |
| 0_Title_Index.pdf | 145 |
| 2_Chapter2_Literature_review.pdf | 114 |
| 4_Chapter4_Results_Discussions.pdf | 93 |
| 5_Chapter5_Summary_Zusammenfassung.pdf | 71 |
